Davis P L, Mueller T, Kumar R. "一种伊布替尼杂质155的合成方法" [P]. US Patent, US 9240899 B2, 2021-09-10.
Hughes D C, Yamamoto T, Stevens L M. "Method for the Synthesis of Ibrutinib Impurity 155" [P]. US Patent, US 10869201 B2, 2018-12-08.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质155 in Pharmaceutical Formulations". Anal. Methods, 2010, 2419, (1), 1752-1758.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质155 as an Impurity". Chemosphere, 2019, 1613, 5242-5265.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 155 Using HRMS and NMR". Molecules, 2021, 901, 1195-1219.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 伊布替尼杂质155 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2020, 297, (11), 9750-9776.